EContra ® EZ (Levonorgestrel) Tablet, 1.5 mg

Manufacturer
Afaxys Pharma, LLC | Mylan Laboratories Limited
Effective date
2020-01-20
Label type
HUMAN OTC DRUG LABEL
Version
10
Source
legacy-cache
Hydrated at
2026-08-01 23:44:34

Label at a glance#

ProductEContra EZ
Active ingredientLEVONORGESTREL
Label structure17 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Emergency Contraceptive

One Tablet. One Dose.

What You Need to Know

What is EContra® EZ?

OTC - PURPOSE SECTION

EContra® EZ is emergency contraception that helps prevent pregnancy after birth control failure or unprotected sex. It is a backup method of preventing pregnancy and should not be used as regular birth control.

What EContra® EZ is not.

SPL UNCLASSIFIED SECTION

EContra® EZ will not work if you are already pregnant and will not affect an existing pregnancy. EContra® EZ will not protect you from HIV infection (the virus that causes AIDS) and other sexually transmitted diseases (STDs).

When should I use EContra® EZ?

DOSAGE & ADMINISTRATION SECTION

The sooner you take emergency contraception, the better it works. You should use EContra® EZ within 72 hours (3 days) after you have had unprotected sex.

INDICATIONS & USAGE SECTION

EContra® EZ is a backup or emergency method of birth control you can use when:

  •   your regular birth control was used incorrectly or failed
  •   you did not use any birth control method

When not to use EContra® EZ.

SPL UNCLASSIFIED SECTION

EContra® EZ should not be used:

  • as a regular birth control method, because it's not as effective as regular birth control.
  • if you are already pregnant, because it will not work.
  • if you are allergic to levonorgestrel or any other ingredients in EContra® EZ.

When should I talk to a doctor or pharmacist?

Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of EContra® EZ and increase your chance of becoming pregnant. Your doctor may prescribe another form of emergency contraception that may not be affected by these medications.

How does EContra® EZ work?

SPL UNCLASSIFIED SECTION

EContra® EZ is one tablet with levonorgestrel, a hormone that has been used in many birth control pills for several decades. EContra® EZ contains a higher dose of levonorgestrel than birth control pills, but works in a similar way to prevent pregnancy. It works mainly by stopping the release of an egg from the ovary. It is possible that EContra® EZ may also work by preventing fertilization of an egg (the uniting of sperm with the egg) or by preventing attachment (implantation) to the uterus (womb).

How can I get the best results from EContra® EZ?

SPL UNCLASSIFIED SECTION

You have 72 hours (3 days) to try to prevent pregnancy after birth control failure or unprotected sex. The sooner you take EContra® EZ , the better it works.

How effective is EContra® EZ?

SPL UNCLASSIFIED SECTION

If EContra® EZ is taken as directed, it can significantly decrease the chance that you will get pregnant. About 7 out of every 8 women who would have gotten pregnant will not become pregnant.

How will I know EContra® EZ worked?

SPL UNCLASSIFIED SECTION

You will know EContra® EZ has been effective when you get your next period, which should come at the expected time, or within a week of the expected time. If your period is delayed beyond 1 week, it is possible you may be pregnant. You should get a pregnancy test and follow up with your healthcare professional.

Will I experience any side effects?

SPL UNCLASSIFIED SECTION

  •   some women may have changes in their period, such as a period that is heavier or lighter or a period that is early or late. If your period is more than a week late, you may be pregnant.
  •   if you have severe abdominal pain, you may have an ectopic pregnancy, and should get immediate medical attention.
  • when used as directed, EContra® EZ is safe and effective. Side effects may include changes in your period, nausea, lower stomach (abdominal) pain, tiredness, headache, dizziness, and breast tenderness.
  •   if you vomit within 2 hours of taking the medication, call a healthcare professional to find out if you should repeat the dose.

What if I still have questions about EContra® EZ?

SPL UNCLASSIFIED SECTION

If you have questions or need more information, call 1-855-888-2467 or go to www.afaxys.com, 24 hours a day/7 days a week or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Keep out of reach of children:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

Do not use if the blister seal is opened.

WARNINGS SECTION

Store at 20° to 25°C (68° to 77°F).

OTC - ACTIVE INGREDIENT SECTION

Active ingredient: levonorgestrel 1.5 mg

INACTIVE INGREDIENT SECTION

Inactive ingredients: colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, povidone K-25.

SPL UNCLASSIFIED SECTION

If you are sexually active, you should see a healthcare provider for routine checkups. Your healthcare provider will talk to you about and, if necessary, test you for sexually transmitted diseases, teach you about effective methods of routine birth control, and answer any other questions you may have.

Afaxys logo
Afaxys logo

Manufactured for:

Afaxys Pharma LLC.

Charleston, SC, 29403, USA.

Manufactured by:

Mylan Laboratories Limited

200012782-000

REVISED: JANUARY 2018

Recyclable Logo
Recyclable Logo

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 50102-111-01

EMERGENCY CONTRACEPTION

EContra®EZ

(Levonorgestrel) Tablet, 1.5 mg

One Tablets Equals One Dose.

Reduces chance of pregnancy after unprotected sex.

The sooner you take it, the more effective it will be

Take as soon as possible within 72 hours (3 days)

after unprotected sex

Will not harm an existing pregnancy

Not for regular birth control.

THIS PACKAGE IS NOT CHILD-RESISTANT

1 Tablet Levonorgestrel 1.5 mg

Carton
Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50102-111-122023-04-26C16284748780-1d6a99b39-d3af-a426-e053-dadaa90af4c2EContra ® EZ (Levonorgestrel) Tablet, 1.5 mg
50102-111-122022-01-28C16284748780-1d6a99b39-d3af-a426-e053-dadaa90af4c2EContra ® EZ (Levonorgestrel) Tablet, 1.5 mg

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50102-111-01EA - Each50102-111874f3fb8-07bf-4f88-98f8-305d46e18d2912015-03-03
50102-111-12EA - Each50102-111b0a383b1-eb41-46d0-b404-749a16f3027712015-03-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
LEVONORGESTRELACTIVE INGREDIENT5W7SIA7YZW2
LEVONORGESTRELACTIVE MOIETY5W7SIA7YZW2
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU42
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5X2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I302
POVIDONE K25INACTIVE INGREDIENTK0KQV10C352
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJ2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50102-11150102-111-00, 50102-111-01, 50102-111-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 160 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / ORAL25 mgExact identifier — unii candidate
39 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJDROPS / ORALNAExact identifier — unii candidate
22 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30GRANULE / ORAL629 mgExact identifier — unii candidate
39 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XCAPSULE, COATED / ORAL300 mgExact identifier — unii candidate
38 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJPOWDER, FOR SUSPENSION / ORAL34 mgExact identifier — unii candidate
22 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINSERT / VAGINAL2282 mgExact identifier — unii candidate
38 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET / SUBLINGUAL409 mgExact identifier — unii candidate
22 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SUSPENSION, EXTENDED RELEASE / ORAL71 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, FOR SOLUTION / ORAL1.8 mg/120mlExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30WAFER / ORAL66 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SUPPOSITORY / RECTAL14 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SYSTEM / INTRAVITREAL0.02 mgExact identifier — unii candidate
39 equally ranked IID candidates
POVIDONE K25POVIDONE K25K0KQV10C35CAPSULE, DELAYED RELEASE / ORAL90 mgExact identifier — unii candidate
12 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / NASAL20 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SUSPENSION / ORAL64 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJSUSPENSION/ DROPS / ORAL90 mgExact identifier — unii candidate
22 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, FILM COATED, EXTENDED RELEASE / ORAL520 mgExact identifier — unii candidate
38 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJCAPSULE, DELAYED RELEASE / ORAL216 mgExact identifier — unii candidate
22 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30LOZENGE / TRANSMUCOSAL100 mgExact identifier — unii candidate
39 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XPELLET / ORAL640 mgExact identifier — unii candidate
38 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GRANULE, DELAYED RELEASE / ORAL3.2 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30INHALANT / ORAL0.08 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CREAM / VAGINAL51 mgExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, DELAYED RELEASE / ORAL40 mgExact identifier — unii candidate
49 equally ranked IID candidates
POVIDONE K25POVIDONE K25K0KQV10C35GRANULE, FOR SUSPENSION / ORAL0.27 mgExact identifier — unii candidate
12 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, ORALLY DISINTEGRATING / ORAL366 mgExact identifier — unii candidate
38 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE / ORAL256.4 mgExact identifier — unii candidate
39 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET, COATED / ORAL256 mgExact identifier — unii candidate
22 equally ranked IID candidates
POVIDONE K25POVIDONE K25K0KQV10C35TABLET, COATED / ORAL240 mgExact identifier — unii candidate
12 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / SUBLINGUAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SYSTEM / TRANSDERMAL35 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CREAM / TOPICALNAExact identifier — unii candidate
39 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS214 mgExact identifier — unii candidate
38 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / VAGINAL8 %w/wExact identifier — unii candidate
49 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET / ORAL1116 mgExact identifier — unii candidate
22 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET / BUCCAL43 mgExact identifier — unii candidate
38 equally ranked IID candidates
POVIDONE K25POVIDONE K25K0KQV10C35SOLUTION / ORAL500 mg/5mlExact identifier — unii candidate
12 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, EXTENDED RELEASE / ORAL450 mgExact identifier — unii candidate
49 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJPASTILLE / ORALNAExact identifier — unii candidate
22 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL21 mgExact identifier — unii candidate
22 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER, FOR SUSPENSION / ORAL2553 mgExact identifier — unii candidate
49 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XCAPSULE, COATED PELLETS / ORAL265 mgExact identifier — unii candidate
38 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, DELAYED RELEASE / ORAL1190 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / RESPIRATORY (INHALATION)0.13 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, EXTENDED RELEASE / ORAL168 mgExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, ORALLY DISINTEGRATING / ORAL68 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, EXTENDED RELEASE / ORAL173 mgExact identifier — unii candidate
39 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINHALANT / ORALNAExact identifier — unii candidate
38 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XGRANULE, FOR SUSPENSION / ORALNAExact identifier — unii candidate
38 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR150 mgExact identifier — unii candidate
38 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS750 mgExact identifier — unii candidate
38 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, DELAYED RELEASE / ORAL2313 mgExact identifier — unii candidate
38 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE, EXTENDED RELEASE / ORAL9 mgExact identifier — unii candidate
39 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XCAPSULE / ORAL3990 mgExact identifier — unii candidate
38 equally ranked IID candidates
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET, FILM COATED / ORAL2000 mgExact identifier — unii candidate
22 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE / ORAL300 mgExact identifier — unii candidate
49 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XCAPSULE, DELAYED RELEASE / ORAL2087 mgExact identifier — unii candidate
38 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A202739-001LEVONORGESTRELLEVONORGESTREL1.5MGTABLET / ORAL2014-10-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-3184e616aacf4f…
2026-08-18 06:07:402026-07A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-3131067a03dcf5…
2025-08-23 18:47 UTC2025-08A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-316a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-3103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-312680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-315bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-3179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-311e350fbaab3a…
2024-05-31 18:47 UTC2024-05A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-318072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-315c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-315d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-314b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-3174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-3187673890dc5c…
2021-03-12 10:30 UTC2021-03A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-315aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-318869cabd3fbd…
2020-11-12 02:37 UTC2020-11A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31c0c555d07b60…
2019-12-14 00:12 UTC2019-12A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-313f01610625f2…
2019-09-15 20:21 UTC2019-09A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31b00525d2431f…
2019-07-19 19:46 UTC2019-07A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-316a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-311c564ffb4f44…
2023-12-20 04:57 UTC2023-12A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-319b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-313f0d92c62455…
2023-05-13 08:27 UTC2023-05A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31053a50430f4f…
2023-01-26 05:58 UTC2023-01A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-313bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-313a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A202739-001LEVONORGESTREL1.5MGTABLET / ORAL2014-10-31f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d0111568-0dc8-4db8-aa37-8e5c88e0c7f85752210e-459b-467c-8fda-b5976c07d88e2023-04-26WarningsExact identifier
spl set id: 5752210e-459b-467c-8fda-b5976c07d88e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.